Trials / Completed
CompletedNCT07076459
A Comparative Pharmacokinetic Study of Single-Dose Administration of HR091506 Tablets From Different Batches in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the pharmacokinetic characteristics of HR091506 tablets in different batches in healthy subjects after single administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HR091506 tablet | In each period under fed conditions, subjects received oral administration of either HR091506 tablet（T1）, HR091506 tablet（T2）, or HR091506 tablet（R）. |
Timeline
- Start date
- 2025-07-10
- Primary completion
- 2025-08-18
- Completion
- 2025-08-18
- First posted
- 2025-07-22
- Last updated
- 2025-08-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07076459. Inclusion in this directory is not an endorsement.